Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Assets (2020 - 2026)

Alvotech's (ALVO) quarterly Assets came in at $1.6 billion in Q2 2026, up 13.98% on a YoY basis from $1.4 billion in Q2 2025, and up 11.7% quarter-over-quarter from $1.4 billion in Q1 2026.

Analysis

Alvotech (ALVO) Assets (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Assets for 7 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Assets rose 13.98% year-over-year to $1.6 billion; the trailing twelve-month figure through Jun 2026 stood at $1.6 billion (up 13.98% YoY), and the FY2025 full-year result was $1.5 billion, up 21.75% from the prior year.
  • Assets improved to $1.6 billion in Q2 2026 per ALVO's latest filing, from $1.4 billion in the prior quarter.
  • Across five years, Assets topped out at $1.6 billion in Q2 2026 and bottomed at $774.5 million in Q2 2022.
  • Historically, Assets has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
  • The sharpest annual moves came in 2022 and 2026: Assets surged 38.54% in 2022, then grew 13.98% in 2026.
  • Over 5 years, Assets stood at $828.4 million in 2022, then grew by 14.68% to $950.1 million in 2023, then gained by 28.56% to $1.2 billion in 2024, then gained by 21.75% to $1.5 billion in 2025, then increased by 6.75% to $1.6 billion in 2026.
  • According to Business Quant data, Assets over the past three periods registered $1.6 billion, $1.4 billion, and $1.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 39.86 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 35.04 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 6.08 Bn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 3.78 Bn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 24.79 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 1.59 Bn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 1.49 Bn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 1.74 Bn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 75.75 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - 25.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.59 Bn
Mar 31, 2026 1.42 Bn
Dec 31, 2025 1.49 Bn
Sep 30, 2025 1.41 Bn
Jun 30, 2025 1.39 Bn
Mar 31, 2025 1.25 Bn
Dec 31, 2024 1.22 Bn
Sep 30, 2024 1.23 Bn
Jun 30, 2024 1.07 Bn
Mar 31, 2024 1.06 Bn
Dec 31, 2023 950.09 Mn
Jun 30, 2023 910.66 Mn
Dec 31, 2022 828.44 Mn
Jun 30, 2022 774.50 Mn
Dec 31, 2021 597.98 Mn
Dec 31, 2020 474.42 Mn